The National Institute of Oncology has been the epidemiological, organizational, methodological, treatment, research and training centre of Hungarian oncology for more than half a century now. It can be compared with any other country's national oncology institute, and is the only comprehensive cancer centre in Central-Eastern Europe. It is highly recognized internationally and its patient satisfaction index is above 95%. The Institute's secret is the professional excellence and human strength of its staff.
The Institute's 6 research and 10 clinical departments perform their duties under high intellectual and state-of-the-art technological conditions. In a year we treat for about 16 thousand new inpatients, 20 thousand patients get treatments in multiple sessions and the number of our outpatient events reaches almost up to 500 thousand. The quality of scientific-research work performed can be characterized by a cumulative impact factor of over 360 a year, by hundreds of Hungarian and foreign language publications and lectures, by the specialist training of clinical oncologists and radiotherapists, as well as the organization of the continuous training of Hungarian oncologists, and the professional- and textbooks fulfilling a great need.
The National Institute of Oncology plays a significant role in the undergraduate education of medical professionals as the Departments of Oncology and Thoracic Surgery of Semmelweis University are based at the Institute’s premises.
The Institute has scientific partnerships with leading cancer institutes across 3 continents.
The NIO has developed, internationally qualified as well as oversees the Hungarian National Cancer Control Program, which had determined the developmental direction of Hungarian oncology for the past decade and which has been the foundation of the oncological chapters of the national health government policies.
The Institute houses and oversees the Hungarian National Cancer Registry.
The Institute is continuously engaged in current matters regarding the structure and activity of Hungarian oncology, it considers its duty to support universities, hospitals, the National Board of Oncology, the Hungarian League Against Cancer and many other professional- and social associations.
Fortiter in re, suaviter in modo.
Prof. Dr. Csaba POLGÁR